Profil
Kamalam Unninayar served as the Chief Financial Officer at Harvard Bioscience, Inc. from 2018 to 2019 and at Tetraphase Pharmaceuticals, Inc. from 2017 to 2018.
She received a graduate degree from Wichita State University and both undergraduate and graduate degrees from the University of Delhi.
Anciens postes connus de Kamalam Unninayar
| Sociétés | Poste | Fin |
|---|---|---|
| HARVARD BIOSCIENCE, INC. | Directeur Financier/CFO | 31/05/2019 |
| TETRAPHASE PHARMACEUTICALS, INC. | Directeur Financier/CFO | 16/03/2018 |
Formation de Kamalam Unninayar
| Wichita State University | Graduate Degree |
| University of Delhi | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HARVARD BIOSCIENCE, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
